Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157618 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Roshani Narayan Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Nasal Mucosa, Cystic Fibrosis, Epithelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Förderungsgesellschaft zur Mukoviszidoseforschung e.V., Deutsche Förderungsgesllschaft zur Mukoviszidoseforschung e.V..
Abstract (Originalsprache)
Cystic fibrosis (CF), the most common hereditary lung disease in Caucasians, is caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR). We evaluated CFTR function using a newly developed Ussing chamber system, the Multi Trans Epithelial Current Clamp (MTECC), in an in vitro model of human airway epithelia. Air–liquid interface (ALI) cultures were established from nasal brushings of healthy controls (HC) and CF patients with biallelic CFTR variants. ALI layer thickness was similar between groups (HC: 62 ± 13 µm; CF: 55 ± 9 µm). Immunofluorescence showed apical CFTR expression in HC, but reduced or absent signal in CF cultures. MTECC enabled continuous measurement of transepithelial resistance (Rt), potential difference (PD), and conductance (Gt). Gt was significantly reduced in CF cultures compared to HC (0.825 ± 0.024 vs. −0.054 ± 0.016 mS/cm2), indicating impaired cAMP-inducible ion transport by CFTR. Treatment of CF cultures with elexacaftor, tezacaftor, and ivacaftor (Trikafta®) increased Gt, reflecting partial restoration of CFTR function. These findings demonstrate the utility of MTECC in detecting functional differences in CFTR activity and support its use as a platform for evaluating CFTR-modulating therapies. Our model may contribute to the development of personalized treatment strategies for CF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
- EP Design, Tervuursesteenweg 154, B-3060 Bertem, Belgium.
ORCID-Profile: Heymut Omran, Wolf-Michael Weber, Jörg Grosse-Onnebrink
Förderung
- Deutsche Förderungsgesellschaft zur Mukoviszidoseforschung e.V.
- Deutsche Förderungsgesllschaft zur Mukoviszidoseforschung e.V.
Zitieren
APA
Singh, R. N., Mete, V., van Driessche, W., Omran, H., Weber, W. M., & Grosse-Onnebrink, J. (2025). Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157618
Vancouver
Singh RN, Mete V, van Driessche W, Omran H, Weber WM, Grosse-Onnebrink J. Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157618
BibTeX
@article{Singh2025,
author = {Singh, Roshani Narayan and Mete, Vanessa and van Driessche, Willy and Omran, Heymut and Weber, Wolf-Michael and Grosse-Onnebrink, Jörg},
title = {Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157618}
}
EUVIMED